What if managing diabetes didn’t always mean another shot? With the FDA’s approval of Afrezza for kids and teens, diabetes management can be easier, faster, and more flexible for everyday life. Here’s why families are so excited about this needle-free insulin option.
read more →
High blood sugar isn’t always the primary warning sign for DKA. A lesser-known type of DKA can happen when glucose levels are below 250 mg/dL, making it one of the easiest diabetes emergencies to miss. Here’s how to recognize the signs.
read more →
Most people think DKA only occurs when T1D is first diagnosed or when infusion lines fail. But you aren’t out of the woods if you have type 2 diabetes, use a patch pump, or are on MDI. DKA can happen for other reasons, and often at times when it’s least expected.
read more →
Although Afrezza isn’t officially approved for use with AID systems, Dr. Edelman and Dr. Pettus use it all the time, and they prescribe it to many of their patients who are on pumps. Learn how inhaled insulin can be a compliment to AID systems, when it works best, and when you need to be cautious.
read more →
2026 is gearing up to be another milestone year in diabetes innovations. From continuous ketone monitoring to once-weekly insulin and new GLP-1 combinations like the “Triple G”, it should be an exciting year! Here are the biggest advancements coming down the pike.
read more →
